本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Context Therapeutics Inc.

0.3790
+0.01464.01%
盤後0.38500.0060+1.58%19:30 EDT
成交量:212.91萬
成交額:79.93萬
市值:3,482.22萬
市盈率:-0.78
高:0.3900
開:0.3700
低:0.3601
收:0.3644
52周最高:3.62
52周最低:0.3434
股本:9,187.92萬
流通股本:6,373.36萬
量比:1.90
換手率:3.34%
股息:- -
股息率:- -
每股收益(TTM):-0.4828
每股收益(LYR):-0.3800
淨資產收益率:-76.14%
總資產收益率:-45.70%
市淨率:0.91
市盈率(LYR):-1.00

資料載入中...

2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

SEC問詢函

Form CORRESP - Correspondence
2024/11/06

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/23

重要事件披露

Form 8-K - Current report
2024/09/17

重要事件披露

Form 8-K - Current report
2024/09/04

重要事件披露

Form 8-K - Current report
2024/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/10

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/30

SEC問詢函

Form CORRESP - Correspondence
2024/05/24

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/10

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

重要事件披露

Form 8-K - Current report